|
|
|
|
|
|
By Brock Schuman, Ph.D., Azor Biotek | Beyond mRNA's dogmatic role as the intermediate in gene expression, noncoding RNA play essential roles in transcription regulation, maturation, and translation. This article explores the potential of RNA as a clinically validated avenue for drug development, methods for design and discovery, and implications for the future of medicine. |
|
|
|
| Fixed-Dose Combination Drugs | Case Study | Cambrex | A company was seeking a CDMO partner with the expertise and technological capabilities to combine three drug substances into a fixed-dose combination product suitable for adult and pediatric dosing. |
|
|
| Ultra-High Potency Development And Manufacture | Case Study | Cambrex | A biotech with limited experience in the development and manufacture of high potency compounds sought to develop a process for producing a highly potent API used to treat an unmet oncology need. |
|
|
| Developing Biosimilars: Challenges And Solutions | Infographic | Sartorius | Biophysical characterization requires technologies that often require expensive reagents, large quantities of samples, and experimental conditions optimization. Simplified analytical workflows can help. |
|
|
|
| Local Delivery For Treatment Of Lung Cancer | Webinar | Lonza | Explore two case studies where lung cancer therapies were delivered to the lung by dry powder inhaler in a rat model and evaluated for efficacy, confirming local delivery is a promising route to treat lung cancer. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIFE SCIENCE LEADER MAGAZINE |
|
|
|
Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business. |
|
|
